Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.
about
Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Open-label trial on efficacy a ...... th advanced pancreatic cancer.
@en
Open-label trial on efficacy a ...... h tegafur and levofolinic acid
@nl
type
label
Open-label trial on efficacy a ...... th advanced pancreatic cancer.
@en
Open-label trial on efficacy a ...... h tegafur and levofolinic acid
@nl
prefLabel
Open-label trial on efficacy a ...... th advanced pancreatic cancer.
@en
Open-label trial on efficacy a ...... h tegafur and levofolinic acid
@nl
P2093
P2860
P1476
Open-label trial on efficacy a ...... th advanced pancreatic cancer.
@en
P2093
ACROSS group
Aleydis Pisa Gatell
Carles Pericay Pijaume
Emma Dotor Navarro
Eugeni Saigí Grau
Gaspar Esquerdo Galiana
Inmaculada Guasch Jordán
Jordi Alfaro Gamero
Juan Manuel Campos Cervera
Manuel Gallén Castillo
P2860
P2888
P356
10.1007/S12094-011-0618-9
P577
2011-01-01T00:00:00Z